{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T21:32:00Z","timestamp":1789421520610,"version":"build-2803163510"},"reference-count":23,"publisher":"Sociedade Brasileira de Pneumologia e Tisiologia","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Bras Pneumol."],"abstract":"<jats:p>Objectives: The 9th edition of the Tumor, Node, Metastasis (TNM-9) lung cancer classification is set to replace the 8th edition (TNM-8) starting in 2025. Key updates include the splitting of the mediastinal nodal category N2 into single- and multiple-station involvement, as well as the classification of multiple extrathoracic metastatic lesions as involving a single organ system (M1c1) or multiple organ systems (M1c2). This study aimed to assess how the TNM-9 revisions affect the final staging of lung cancer patients and how these changes correlate with overall survival (OS). Methods: This retrospective cohort study included patients diagnosed with lung cancer between 2018 and 2021, who were staged according to both TNM-8 and TNM-9 criteria. The staging classifications were analyzed and compared in relation to OS. Results: Among a total of 914 patients, 42 were re-staged using TNM-9. Of the 382 patients classified as stage IVB, 55.9% were reclassified as M1c2. Despite an absolute increase in mean OS for patients re-staged from IIB to IIA and from IIIA to IIB, the observed differences were not statistically significant. Median OS differed significantly both within stage IVB and between patients with M1c2 disease and other stage IV subgroups. Multi-organ metastatic disease was an independent predictor of poorer OS, regardless of age, sex, performance status, and oncologic treatment. Conclusions: TNM-9 improves prognostic accuracy in lung cancer. Although patients with multiple extrathoracic metastases involving different organ systems are not yet independently staged from IVB, they demonstrated significantly poorer OS compared to other advanced-stage patients.<\/jats:p>","DOI":"10.36416\/1806-3756\/e20250022","type":"journal-article","created":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T19:14:38Z","timestamp":1748978078000},"page":"e20250022","source":"Crossref","is-referenced-by-count":3,"title":["Out with the old \u2013 advancements and shortcomings of the updated 9th edition of the Tumor, Node, Metastasis (TNM) classification system for lung cancer"],"prefix":"10.36416","author":[{"given":"Pedro","family":"Magalh\u00e3es Ferreira1","sequence":"first","affiliation":[{"name":"1. Departamento de Pneumologia, Centro Hospitalar Universit\u00e1rio de S\u00e3o Jo\u00e3o, Porto, Portugal."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Campos2","sequence":"additional","affiliation":[{"name":"2. Faculdade de Medicina, Universidade do Porto, Porto, Portugal."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Valente1","sequence":"additional","affiliation":[{"name":"1. Departamento de Pneumologia, Centro Hospitalar Universit\u00e1rio de S\u00e3o Jo\u00e3o, Porto, Portugal."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Valente1","sequence":"additional","affiliation":[{"name":"1. Departamento de Pneumologia, Centro Hospitalar Universit\u00e1rio de S\u00e3o Jo\u00e3o, Porto, Portugal."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana","family":"Ferreira1","sequence":"additional","affiliation":[{"name":"1. Departamento de Pneumologia, Centro Hospitalar Universit\u00e1rio de S\u00e3o Jo\u00e3o, Porto, Portugal."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e1udia","family":"Freitas1,2","sequence":"additional","affiliation":[{"name":"1. Departamento de Pneumologia, Centro Hospitalar Universit\u00e1rio de S\u00e3o Jo\u00e3o, Porto, Portugal. 2. Faculdade de Medicina, Universidade do Porto, Porto, Portugal."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catarina","family":"Sousa1,2","sequence":"additional","affiliation":[{"name":"1. Departamento de Pneumologia, Centro Hospitalar Universit\u00e1rio de S\u00e3o Jo\u00e3o, Porto, Portugal. 2. Faculdade de Medicina, Universidade do Porto, Porto, Portugal."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Ara\u00fajo1,2","sequence":"additional","affiliation":[{"name":"1. Departamento de Pneumologia, Centro Hospitalar Universit\u00e1rio de S\u00e3o Jo\u00e3o, Porto, Portugal. 2. Faculdade de Medicina, Universidade do Porto, Porto, Portugal."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9lder","family":"Novais Bastos1,2,3","sequence":"additional","affiliation":[{"name":"1. Departamento de Pneumologia, Centro Hospitalar Universit\u00e1rio de S\u00e3o Jo\u00e3o, Porto, Portugal. 2. Faculdade de Medicina, Universidade do Porto, Porto, Portugal. 3. Instituto de Patologia Molecular e Imunologia, Universidade do Porto, Porto, Portugal."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Magalh\u00e3es1,2","sequence":"additional","affiliation":[{"name":"1. Departamento de Pneumologia, Centro Hospitalar Universit\u00e1rio de S\u00e3o Jo\u00e3o, Porto, Portugal. 2. Faculdade de Medicina, Universidade do Porto, Porto, Portugal."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Gabriela O. Fernandes1,2,3","sequence":"additional","affiliation":[{"name":"1. Departamento de Pneumologia, Centro Hospitalar Universit\u00e1rio de S\u00e3o Jo\u00e3o, Porto, Portugal. 2. Faculdade de Medicina, Universidade do Porto, Porto, Portugal. 3. Instituto de Patologia Molecular e Imunologia, Universidade do Porto, Porto, Portugal."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"22288","published-online":{"date-parts":[[2025,6,3]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"1.           Jakobsen E, Olsen KE, Bliddal M, Hornbak M, Persson GF, Green A. Forecasting lung cancer incidence, mortality, and prevalence to year 2030. BMC Cancer. 2021;21(1):985. https:\/\/doi.org\/10.1186\/s12885-021-08696-6.","DOI":"10.1186\/s12885-021-08696-6"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"2.           Hwang JK, Page BJ, Flynn D, Passmore L, McCaul E, Brady J, et al. Validation of the Eighth Edition TNM Lung Cancer Staging System. J Thorac Oncol. 2020;15(4):649\u201354. https:\/\/doi.org\/10.1016\/j.jtho.2019.11.030.","DOI":"10.1016\/j.jtho.2019.11.030"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"3.           Detterbeck FC, Boffa DJ, Kim AW, Tanoue LT. The Eighth Edition Lung Cancer Stage Classification. Chest. 2017;151(1):193\u2013203. https:\/\/doi.org\/10.1016\/j.chest.2016.10.010.","DOI":"10.1016\/j.chest.2016.10.010"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"4.           Detterbeck FC, Woodard GA, Bader AS, Dacic S, Grant MJ, Park HS, et al. The Proposed Ninth Edition TNM Classification of Lung Cancer. Chest. 2024;166(4):882\u201395. https:\/\/doi.org\/10.1016\/j.chest.2024.05.026.","DOI":"10.1016\/j.chest.2024.05.026"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"5.           Xu L, Si H, Su H, Wang F, Wu J, She Y, et al. The number of metastatic lymph nodes is more predictive of prognosis than location-based N stage for non-small cell lung cancer: a retrospective cohort study. Int J Surg. 2023;109(12):4126\u201334. https:\/\/doi.org\/10.1097\/JS9.0000000000000723.","DOI":"10.1097\/js9.0000000000000723"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"6.           Goldstraw P, Crowley J, Chansky K, Giroux DJ, Groome PA, Rami-Porta R, et al. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol. 2007;2(8):706\u201314. https:\/\/doi.org\/10.1097\/JTO.0b013e31812f3c1a.","DOI":"10.1097\/jto.0b013e31812f3c1a"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"7.           Asamura H, Chansky K, Crowley J, Goldstraw P, Rusch VW, Vansteenkiste JF, et al. The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for the Revision of the N Descriptors in the Forthcoming 8th Edition of the TNM Classification for Lung Cancer. J Thorac Oncol. 2015;10(12):1675\u201384. https:\/\/doi.org\/10.1097\/JTO.0000000000000678.","DOI":"10.1097\/jto.0b013e31807ec803"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"8.           Rami-Porta R, Nishimura KK, Giroux DJ, Detterbeck F, Cardillo G, Edwards JG, et al. The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groups in the Forthcoming (Ninth) Edition of the TNM Classification for Lung Cancer. J Thorac Oncol. 2024;19(7):1007\u201327. https:\/\/doi.org\/10.1016\/j.jtho.2024.02.011.","DOI":"10.1016\/j.jtho.2024.02.011"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"9.           Faria N, Costa MI, Lacerda C, Sucena M. Impact of the Ninth International Association for the Study of Lung Cancer TNM Classification on Endobronchial Ultrasound for Lung Cancer Staging. J Thorac Oncol. 2024;19(10):e53\u2013e55. https:\/\/doi.org\/10.1016\/j.jtho.2024.07.010","DOI":"10.1016\/j.jtho.2024.07.010"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"10.        Rami-Porta R, Call S, Dooms C, Obiols C, S\u00e1nchez M, Travis WD, et al. Lung cancer staging: a concise update. Eur Respir J. 2018;51(5):1800190. https:\/\/doi.org\/10.1183\/13993003.00190-2018.","DOI":"10.1183\/13993003.00190-2018"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"11.        Vilmann P, Clementsen PF, Colella S, Siemsen M, De Leyn P, Dumonceau JM, et al. Combined endobronchial and esophageal endosonography for the diagnosis and staging of lung cancer: European Society of Gastrointestinal Endoscopy (ESGE) Guideline, in cooperation with the European Respiratory Society (ERS) and the European Society of Thoracic Surgeons (ESTS). Endoscopy. 2015;47(06):545\u201359. https:\/\/doi.org\/10.1055\/s-0034-1392040.","DOI":"10.1055\/s-0034-1392040"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"12.        Fujiwara T, Yasufuku K, Nakajima T, Chiyo M, Yoshida S, Suzuki M, et al. The Utility of sonographic features during endobronchial ultrasound-guided transbronchial needle aspiration for lymph node staging in patients with lung cancer: a standard endobronchial ultrasound image classification system. Chest. 2010;138(3):641\u20137. https:\/\/doi.org\/10.1378\/chest.09-2006.","DOI":"10.1378\/chest.09-2006"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"13.        Nakajima T, Anayama T, Shingyoji M, Kimura H, Yoshino I, Yasufuku K. Vascular image patterns of lymph nodes for the prediction of metastatic disease during EBUS-TBNA for mediastinal staging of lung cancer. J Thorac Oncol. 2012;7(6):1009\u201314. https:\/\/doi.org\/10.1097\/JTO.0b013e31824cbafa.","DOI":"10.1097\/jto.0b013e31824cbafa"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"14.        Schmidt-Hansen M, Baldwin DR, Hasler E, Zamora J, Abraira V, Roqu\u00e9 I Figuls M. PET-CT for assessing mediastinal lymph node involvement in patients with suspected resectable non-small cell lung cancer. Cochrane Database Syst Rev. 2014;2014(11):CD009519. https:\/\/doi.org\/10.1002\/14651858.CD009519.pub2","DOI":"10.1002\/14651858.cd009519.pub2"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"15.        Fong KM, Rosenthal A, Giroux DJ, Nishimura KK, Erasmus J, Lievens Y, et al. The International Association for the Study of Lung Cancer Staging Project for Lung Cancer: Proposals for the Revision of the M Descriptors in the Forthcoming Ninth Edition of the TNM Classification for Lung Cancer. J Thorac Oncol. 2024;19(5):786\u2013802. https:\/\/doi.org\/10.1016\/j.jtho.2024.01.019.","DOI":"10.1016\/j.jtho.2024.01.019"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"16.        S\u00e1nchez de Cos Escu\u00edn J, Abal Arca J, Melchor \u00cd\u00f1iguez R, Miravet Sorribes L, N\u00fa\u00f1ez Ares A, Hern\u00e1ndez Hern\u00e1ndez JR, et al. Tumor, node and metastasis classification of lung cancer \u2013 M1a versus M1b \u2013 analysis of M descriptors and other prognostic factors. Lung Cancer. 2014;84(2):182\u20139. https:\/\/doi.org\/10.1016\/j.lungcan.2014.02.006.","DOI":"10.1016\/j.lungcan.2014.02.006"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"17.        Dias M, Antunes A, Campainha S, Conde S, Barroso A. Prognostic impact of M descriptors of the 8th edition of TNM classification of lung cancer. J Thorac Dis. 2017;9(3):685\u201391. https:\/\/doi.org\/10.21037\/jtd.2017.03.106.","DOI":"10.21037\/jtd.2017.03.106"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"18.        Hellman S, Weichselbaum RR. Oligometastases. J Clin Oncol. 1995;13(1):8\u201310. https:\/\/doi.org\/10.1200\/JCO.1995.13.1.8.","DOI":"10.1200\/JCO.1995.13.1.8"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"19.        Shultz DB, Filippi AR, Thariat J, Mornex F, Loo BW, Ricardi U. Stereotactic ablative radiotherapy for pulmonary oligometastases and oligometastatic lung cancer. J Thorac Oncol. 2014;9(10):1426\u201333. https:\/\/doi.org\/10.1097\/JTO.0000000000000317.","DOI":"10.1097\/jto.0000000000000317"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"20.        Treasure T. Oligometastatic cancer: an entity, a useful concept, or a therapeutic opportunity? J R Soc Med. 2012;105(6):242\u20136. https:\/\/doi.org\/10.1258\/jrsm.2011.110279.","DOI":"10.1258\/jrsm.2011.110279"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"21.        Suzuki H, Yoshino I. Approach for oligometastasis in non-small cell lung cancer. Gen Thorac Cardiovasc Surg. 2016;64(4):192\u20136. https:\/\/doi.org\/10.1007\/s11748-016-0630-7.","DOI":"10.1007\/s11748-016-0630-7"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"22.        Noh JM, Ahn YC. How aggressive one need to be in treatment of patients with oligometastasis from non-small cell lung cancer? J Thorac Dis. 2017;9(4):E378\u2013E380. https:\/\/doi.org\/10.21037\/jtd.2017.04.06.","DOI":"10.21037\/jtd.2017.04.06"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"23.        Giaj-Levra N, Giaj Levra M, Berghmans T, Novello S, Hendriks LE, Levy A, et al. Oligometastatic non-small cell lung cancer (NSCLC): Does number of metastasis matter? Lung Cancer. 2020;139:216\u20138. https:\/\/doi.org\/10.1016\/j.lungcan.2019.11.005.","DOI":"10.1016\/j.lungcan.2019.11.005"}],"container-title":["Jornal Brasileiro de Pneumologia"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T17:26:36Z","timestamp":1749057996000},"score":1,"resource":{"primary":{"URL":"https:\/\/jornaldepneumologia.com.br\/details\/4109\/en-US"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,3]]},"references-count":23,"URL":"https:\/\/doi.org\/10.36416\/1806-3756\/e20250022","relation":{},"ISSN":["1806-3756"],"issn-type":[{"value":"1806-3756","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,3]]}}}